SCHEMBL7954096

SCHEMBL7954096

CCOC(=O)c1cc2c(C)cccc2n1CCOCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.53
▸ KDM4E B2RXH2 5/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ TSHR P16473 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ RECQL P46063 1/20 0.43
▸ NOD2 Q9HC29 2/20 0.43
▸ NOD1 Q9Y239 2/20 0.43
▸ POLB P06746 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ ATM Q13315 1/20 0.39
▸ SLC9A1 P19634 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7954133 0.91 F10 (0.53) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7955701 0.86 F10 (0.57) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7961092 0.84 F10 (0.55) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7947022 0.79 F10 (0.55) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7956172 0.78 F10 (0.52) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7957934 0.76 F10 (0.53) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL5623862 0.76 F10 (0.57) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7954098 0.75 F10 (0.46) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL7960876 0.74 F10 (0.50) F10KDM4ECRHBPCRHR2SMN1; SMN2
SCHEMBL17323120 0.74 F10 (0.57) F10KDM4ECRHBPCRHR2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271251-B1 CARDIOVASCULAR DISORDERS SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2001-08-07 — — US disclosed
US-5977100-A Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5834454-A TREATMENT OF ANGINA, ISCHEMIA, ARRHYTHMIA SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
EP-0787728-A1 Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-08-06 — — EP disclosed
Send feedback